Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Biotech Drug Factory

A photo essay: Inside Genetech’s South San Francisco manufacturing plant

Last year, Genentech, a global leader in the manufacture of genetically engineered drugs, had sales of about $5.5 billion. A “biotech drug” is one that uses a protein to treat a particular disorder: to make its protein-based drugs, which include cancer treatments and a human growth hormone, Genentech must grow vast quantities of therapeutic proteins in host cells and then harvest them.

The company can ferment approximately 280,000 liters of cell culture at any one time at its various manufacturing plants.

This photo essay illustrates the production process at Genentech’s South San Francisco plant, from the testing and fine-tuning of manufacturing techniques, to the fermentation of cells, to the purification of drugs that will be shipped around the world.

This story is part of our March/April 2006 Issue
See the rest of the issue
Subscribe

[Click here for the images.]

AI is here.
Own what happens next at EmTech Digital 2019.

Register now
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Online Only.
  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.